{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "67751-243",
      "generic_name": "Acetaminophen, Aspirin, and Caffeine",
      "labeler_name": "Navajo Manufacturing Company Inc.",
      "brand_name": "Excedrin Migraine",
      "brand_name_suffix": "Migraine",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "250 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "250 mg/1"
        },
        {
          "name": "CAFFEINE",
          "strength": "65 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "67751-243-02",
          "description": "2 POUCH in 1 CARTON (67751-243-02)  / 2 TABLET, FILM COATED in 1 POUCH",
          "marketing_start_date": "20250313",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Navajo Manufacturing Company Inc."
        ],
        "rxcui": [
          "209468",
          "308297"
        ],
        "spl_set_id": [
          "4efbd21b-92fe-96a7-e063-6294a90ac4ad"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832",
          "N0000175739",
          "N0000175729",
          "N0000175790",
          "M0023046"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]",
          "Central Nervous System Stimulation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]",
          "Xanthines [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]",
          "Central Nervous System Stimulant [EPC]",
          "Methylxanthine [EPC]"
        ],
        "unii": [
          "362O9ITL9D",
          "R16CO5Y76E",
          "3G6A5W338E"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "4efbd22a-bc84-9547-e063-6294a90afe09",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250313",
      "product_id": "67751-243_4efbd22a-bc84-9547-e063-6294a90afe09",
      "application_number": "NDA020802",
      "brand_name_base": "Excedrin",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}